Valneva Se has released a press release.
Pfizer et Valneva annoncent l’acceptation pour revue par l’Agence européenne des médicaments (EMA) de la demande d’autorisation de mise sur le marché de leur candidat vaccin contre la maladie de Lyme
Earlier from Valneva
- Valneva Half-Year 2026 Financial Report
- Declaration of shares and voting rights - Status as of July 31, 2026
- Valneva to Report First Half 2026 Consolidated Financial Results on August 13, 2026
- Declaration voting rights - June 30,2026